Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ependymoma 1

Interventions

X-Rays 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Biopsy 4ulixertinib 2tipifarnib 2selpercatinib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2tazemetostat 1palbociclib 1lutetium Lu 177 dotatate 1Vemurafenib 1Temozolomide 1Pharmacogenomic Variants 1Nivolumab 1Linear Energy Transfer 1LY3023414 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ependymoma × Linear Energy Transfer × 30 days × Clear all
NCT03750513 2026-05-20

LET Optimized IMPT in Treating Pediatric Patients With Ependymoma

M.D. Anderson Cancer Center

Phase 1 Recruiting
48 enrolled

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡